Neoplasms by Site Active Not Recruiting Phase 1 / 2 Trials for Relatlimab (DB14851)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0030096 (Neoplasms by Site) | Active Not Recruiting | 1 / 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01968109 | An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors | Treatment |